FDA approves Tryngolza as adjunct to diet for familial chylomicronemia syndrome

by

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can lead to potentially life-threatening acute pancreatitis (AP), according to a press release issued by Ionis Pharmaceuticals.

Leave A Comment

Your email address will not be published. Required fields are marked *